Patents by Inventor Kenneth E. Truitt

Kenneth E. Truitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human lymphoblastoid cell line and hybridomas derived therefrom
    Patent number: 4897466
    Abstract: A 6-thioguanine-resistant subvariant of the EBV-transformed human lymphoblastoid B cell line WI-L2 is described. The subvariant line, designated LTR228, fuses efficiently with human cells. Human.times.human hybridomas derived from LTR228 that produce monoclonal antibodies against tetanus toxin and blood group A are exemplified.
    Type: Grant
    Filed: June 6, 1986
    Date of Patent: January 30, 1990
    Assignee: Cetus Corporation
    Inventors: James W. Larrick, Andrew R. Raubitschek, Kenneth E. Truitt
  • Human lymphoblastold cell line and hybridomas derived therefrom
    Patent number: 4624921
    Abstract: A 6-thioguanine-resistant subvariant of the EBV-transformed human lymphoblastoid B cell line WI-L2 is described. The subvariant line, designated LTR228, fuses efficiently with human cells. Human.times.human hybridomas derived from LTR228 that produce monoclonal antibodies against tetanus toxin and blood group A are exemplified.
    Type: Grant
    Filed: April 26, 1984
    Date of Patent: November 25, 1986
    Assignee: Cetus Corporation
    Inventors: James W. Larrick, Andrew R. Raubitschek, Kenneth E. Truitt